Endocrinology and metabolism after premature pubarche in girls

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 88, Issue 433, 1999, Pages 73-77

  Ibanez L ^a,b   Potau, N ^b   De Zegher, F ^c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Functional ovarian hyperandrogenism; Hyperinsulinism; Low birth weight; Premature pubarche

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1;

ANOVULATION; CONFERENCE PAPER; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERANDROGENISM; HYPERINSULINISM; MAJOR CLINICAL STUDY; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SCHOOL CHILD;

BIRTH WEIGHT; CHILD; FEMALE; HUMANS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; OVARY; POLYCYSTIC OVARY SYNDROME; PUBERTY, PRECOCIOUS;

EID: 0343485023     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. Ibáñez L, Virdis R, Potau N, Zampolli M, Ghizzoni L, Albisu MA, et al. Natural history of premature pubarche: an auxological study. J Clin Endocrinol Metab 1992; 74: 254-7
2. Rosenfield RL. Normal and almost normal variations in pubertal development. Premature pubarche and premature thelarche revisited. Horm Res 1994; 41(Suppl 2): 7-13
3. Ibáñez L, Potau N, Carrascosa A. Androgens in adrenarche and pubarche. In: Azziz R, Nestler JE, Dewailly D, editors. Androgen excess disorders in women. Philadelphia: Lippincott-Raven, 1997: 73-84
4. Ibáñez L, Bonnin MR, Zampolli M, Prat N, Alia PJ, Navarro MA. Usefulness of an ACTH test in the diagnosis of non- classical 21-hydroxylase deficiency among children presenting with premature pubarche. Horm Res 1995; 44: 51-6
5. De la Puente ML, Canela J, Alvarez J, Salleras L, Vicens-Calvet E. Cross-sectional growth study of the child and adolescent population of Catalonia (Spain). Ann Hum Biol 1997; 24: 435- 52
6. Ibáñez L, Potau N, de Zegher F. Anovulation after precocious pubarche: early markers and time course in adolescence. J Clin Endocrinol Metab 1999; 84: 2691-95
7. Ibáñez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinyé M, et al. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993; 76: 1599-1603
8. Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 1995; 16: 322-53
9. Barnes RB, Rosenfield RL, Burnstein S, Ehrmann DA. Pituitary- ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med 1989; 320: 559-67
10. Ibáñez L, Potau N, Zampolli M, Prat N, Gussinye M, Saenger P, et al. Source localization of androgen excess in adolescent girls. J Clin Endocrinol Metab 1994; 79: 1778-84
11. Ibáñez L, Potau N, Georgopoulos N, Prat N, Gussinyé M, Carrascosa A. Growth hormone, insulin-like growth factor-I axis, and insulin secretion in hyperandrogenic adolescents. Fertil Steril 1995; 64: 1113-9
12. Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DP, Sheikh Z. Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med 1992; 327: 157-62
13. O'Meara NM, Blackman JD, Ehrmann DA, Barnes RB, Jaspan JB, Rosenfield RL, et al. Defects in β-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993; 76: 1241-7
14. Apter D, Bützow T, Laughlin GA, Yen SSC. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. J Clin Endocrinol Metab 1995; 80: 2966-73
15. Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SSC. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab 1996; 81: 2854-64
16. Rosenfield RL. Evidence that idiopathic functional adrenal hyperandrogenism is caused by dysregulation of adrenal steroidogenesis and that hyperinsulinemia may be involved (editorial). J Clin Endocrinol Metab 1996; 81: 878-80
17. Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab 1986; 62: 904-10
18. Cara JF, Rosenfield RL. Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology 1988; 123: 733-9
19. L'Allemand D, Penhoat A, Lebrethon MC, Ardevol R, Baehr V, Oelkers W, et al. Insulin-like growth factors enhance steroidogenic enzyme and corticotropin receptor messenger ribonucleic acid levels and corticotropin steroidogenic responsiveness in cultured human adrenocortical cells. J Clin Endocrinol Metab 1996; 81: 3892-7
20. Mesiano S, Katz LS, Lee JY, Jaffe RB. Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: implications for adrenal androgen production. J Clin Endocrinol Metab 1997; 82: 1390-6
21. Suikkari AM, Koivisto VA, Rutanen EM, Yki-Järvinen H, Karonen SL, Seppäla M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor binding protein. J Clin Endocrinol Metab 1988; 66: 266-72
22. Nestler JE. Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance? (editorial). J Clin Endocrinol Metab 1993; 76: 273-4
23. Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 1996; 335: 617-23
24. Nestler JE, Jakubowicz DJ. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17α activity and serum androgens. J Clin Endocrinol Metab 1997; 82: 4075-9
25. Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R. The insulin sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 1996; 81: 3299-306
26. Ibáñez L, Potau N, Zampolli M, Riqué S, Saenger P, Carrascosa A. Hyperinsulinemia and decreased insulin-like growth factor- binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab 1997; 82: 2283-8
27. Ibáñez L, Potau N, Zampolli M, Prat N, Virdis R, Vicens-Calvet E, et al. Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1996; 81: 1237-43
28. Orchard TJ, Becker DJ, Bates M, Kuller LH, Drash AL. Plasma insulin and lipoprotein concentrations: an atherogenic association? Am J Epidemiol 1983; 118: 326-37
29. Després JP. The insulin resistance-dyslipidemia syndrome: the most prevalent cause of coronary artery disease? CMAJ 1993; 148: 1339-40
30. Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334: 952-7
31. Ibáñez L, Potau N, Chacón P, Pascual C, Carrascosa A. Hyperinsulinaemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia 1998; 41: 1057-63
32. Wild RA, Alaupovic P, Parker IJ. Lipid and lipoprotein abnormalities in hirsute women. I. The association with insulin resistance. Am J Obstet Gynecol 1992; 166: 1191-7
33. Ibáñez L, Potau N, Carrascosa A. Insulin resistance, premature adrenarche, and a risk of the polycystic ovary syndrome (PCOS). TEM 1998; 9: 72-7
34. Arslanian S, Suprasongsin C. Insulin sensitivity, lipids, and body composition in childhood: is "Syndrome X" present? J Clin Endocrinol Metab 1996; 81: 1058-62
35. Ibáñez L, Potau N, Francois I, de Zegher F. Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 1998; 83: 3558-62
36. Ibáñez L, de Zegher F, Potau N. Premature pubarche, ovarian hyperinsulinism, hyperandrogenism and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onset. J Endocrinol Invest 1998; 21: 558-66
37. Ibáñez L, Potau N, de Zegher F. Precocious pubarche, dyslipidemia, and low IGF binding protein-1 in girls: relation to reduced prenatal growth. Pediatr Res 1999; 46: 320-2